The Different Effects of Atorvastatin and Pravastatin on Cell Death and PARP Activity in Pancreatic NIT-1 Cells

Abstract EN

Statins have been widely used drugs for lowering low-density lipoprotein and for preventing heart attack and stroke.

However, the increased risk for developing diabetes during extended stain use and the molecular mechanisms remain unclear.

The objective of this study was to elucidate the signaling pathway and biological function between necrosis and autophagy induced by atorvastatin (AS) and pravastatin (PS).

Here we observed that atorvastatin (AS) can increase intracellular reactive oxygen species (ROS) and induce necrotic cell death and autophagy in NIT-1 cells, whereas pravastatin (PS) does not cause ROS and cell death but also induces autophagy.

PARP1 exhibited a dual role in modulating necrosis and autophagy in AS- and PS-treated NIT-1 cells through RIP1-RIP3-MLKL pathway and PARP1-AMPK-mTOR pathway.

Lastly, AS treatment induced mitochondrial morphology injury significantly more than PS treatment did.

Thus, the PARP1 activation should be considered in the development of effective statin therapies for diabetes.

Future studies may examine specific mechanisms and pathways in mitochondria, autophagy, and oxidative stress in vivo.